146 related articles for article (PubMed ID: 4006049)
1. Combined therapeutic effects of an immunomodulator, PSK, and chemotherapy with carboquone on rat bladder carcinoma.
Mickey DD
Cancer Chemother Pharmacol; 1985; 15(1):54-8. PubMed ID: 4006049
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of a combined application of radiotherapy, carboquone, and PSK in malignant tumor--clinical results at 7 facilities].
Tsuya A; Kaneda K; Mikuriya S; Horiuchi J; Amino S; Mochizuki S; Kamata R; Ikeda M; Okawa T
Gan No Rinsho; 1982; 28(1):49-54. PubMed ID: 7182548
[No Abstract] [Full Text] [Related]
3. [An anticancer drug--carboquone].
Saito T
Gan To Kagaku Ryoho; 1988 Mar; 15(3):549-54. PubMed ID: 3279914
[TBL] [Abstract][Full Text] [Related]
4. Combined therapeutic effects of conventional agents and an immunomodulator, PSK, on rat prostatic adenocarcinoma.
Mickey DD; Carvalho L; Foulkes K
J Urol; 1989 Dec; 142(6):1594-8. PubMed ID: 2585643
[TBL] [Abstract][Full Text] [Related]
5. [Experimental study on immunochemotherapy (PSK, CQ) in rat bladder cancer (BC-47)].
Nakagami Y; Kishimoto T; Matsumoto K
Gan To Kagaku Ryoho; 1985 Oct; 12(10):1968-74. PubMed ID: 4051512
[TBL] [Abstract][Full Text] [Related]
6. [Compound therapy including PSK for malignant head and neck cancer].
Hoshiya T; Matsunaga T; Hyo Y; Mori N; Kakiuchi H; Saeki K; Wakuda K
Gan To Kagaku Ryoho; 1982 Jan; 9(1):91-5. PubMed ID: 7184365
[TBL] [Abstract][Full Text] [Related]
7. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
Ichihashi H; Kondo T; Nakazato H
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635
[TBL] [Abstract][Full Text] [Related]
8. Alternating immunochemotherapy of advanced gastric carcinoma: a randomized comparison of carbazilquinone and PSK to carbazilquinone in patients with curative gastric resection.
Kondo T; Sakamoto J; Nakazato H
Biotherapy; 1991; 3(4):287-95. PubMed ID: 1786194
[TBL] [Abstract][Full Text] [Related]
9. Activation by the protein-bound polysaccharide PSK (krestin) of cytotoxic lymphocytes that act on fresh autologous tumor cells and T24 human urinary bladder transitional carcinoma cell line in patients with urinary bladder cancer.
Mizutani Y; Yoshida O
J Urol; 1991 May; 145(5):1082-7. PubMed ID: 2016797
[TBL] [Abstract][Full Text] [Related]
10. Interaction of antitumor agents including carboquone in sarcoma-180 system.
Iigo M; Nakamura A; Hoshi A; Kuretani K
Gan; 1976 Oct; 67(5):641-4. PubMed ID: 1017581
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of anticancer alkylating agent, carboquone (NSG-134679).
Himori T; Wakui A; Saito T
Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):92-9. PubMed ID: 6678502
[No Abstract] [Full Text] [Related]
12. Potentiation of anticancer effect of carboquone in vivo by glucose pretreatment.
Baba T; Aoki K; Kimura NT; Kamura T; Nishikawa K; Taniguchi S
Gan; 1979 Apr; 70(2):255-8. PubMed ID: 467889
[TBL] [Abstract][Full Text] [Related]
13. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group].
Nakazato H; Ichihashi H; Kondo T
Gan To Kagaku Ryoho; 1986 Feb; 13(2):308-18. PubMed ID: 3947108
[TBL] [Abstract][Full Text] [Related]
14. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy.
Fisher M; Yang LX
Anticancer Res; 2002; 22(3):1737-54. PubMed ID: 12168863
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of bladder neoplasms--instillation of carboquone into the bladder].
Saito S; Takahashi Y; Ooshima H; Matuda G
Nihon Rinsho; 1977 May; 35(5):1983-7. PubMed ID: 560545
[No Abstract] [Full Text] [Related]
16. Tumor growth promoting activity of an immunosuppressive substance and its modulation by protein-bound polysaccharide PSK.
Fujii M; Fujii T; Saito K; Takahashi N; Yoshikumi C; Kakuchi J; Kawai Y
Immunol Lett; 1987 Aug; 15(4):347-51. PubMed ID: 3692538
[TBL] [Abstract][Full Text] [Related]
17. Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1.
Hsu JT; Hsu CS; Le PH; Chen TC; Chou WC; Lin CY; Yeh TS
J Surg Res; 2017 May; 211():30-38. PubMed ID: 28501128
[TBL] [Abstract][Full Text] [Related]
18. Krestin (PSK).
Tsukagoshi S; Hashimoto Y; Fujii G; Kobayashi H; Nomoto K; Orita K
Cancer Treat Rev; 1984 Jun; 11(2):131-55. PubMed ID: 6238674
[TBL] [Abstract][Full Text] [Related]
19. [Effect of carboquone in complete regression of mouse mammary cancer MM-46].
Shinkai K; Arakawa M
Gan To Kagaku Ryoho; 1982 Mar; 9(3):556-7. PubMed ID: 7184412
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker.
Kudo S; Tanaka J; Kashida H; Tamegai Y; Endo S; Yamano HO
Oncol Rep; 2002; 9(3):635-8. PubMed ID: 11956642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
